Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Injectable HIV therapy offers hope for those who struggle with daily pills—providing a powerful, long-lasting alternative to ...

For mild allergic reaction symptoms ... Resistance means that Descovy will be less effective at treating HIV, or it may no longer be effective at all. PrEP treatment refers to taking an HIV ...

Determinants of HIV cell tropism & chemokine receptor usage ... SDF-1α-mediated chemotaxis of cancer cells. Antiarthritis & allergy: CXCR4 inhibitors AMD3100 and T140 are effective in mitigating ...